Get started
JAZZ PHARMA PLCJAZZ PHARMA PLCJAZZ PHARMA PLC

JAZZ PHARMA PLC

No trades
See on Supercharts
Overview
Financials News Ideas Forecast

J7Z chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪6.00 B‬CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
24.028
Basic EPS (TTM)
4.717CHF
Net income (FY)
‪349.26 M‬CHF
Revenue (FY)
‪3.23 B‬CHF
Shares float
‪61.04 M‬
Beta (1Y)
0.42

About Jazz Pharmaceuticals plc

Sector
Health Technology
CEO
Bruce C. Cozadd
Headquarters
Dublin
Website
jazzpharmaceuticals.com
Employees (FY)
‪2.8 K‬
Founded
2005
ISIN
IE00B4Q5ZN47
FIGI
BBG00LVDMT84
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of J7Z is 104.979 CHF — it has increased by 3.72% in the past 24 hours. Watch JAZZ PHARMA PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange JAZZ PHARMA PLC stocks are traded under the ticker J7Z.
J7Z stock hasn't changed in a week, the last month showed zero change in price, over the last year JAZZ PHARMA PLC has showed a 31.64% decrease.
We've gathered analysts' opinions on JAZZ PHARMA PLC future price: according to them, J7Z price has a max estimate of 207.62 CHF and a min estimate of 105.61 CHF. Watch J7Z chart and read a more detailed JAZZ PHARMA PLC stock forecast: see what analysts think of JAZZ PHARMA PLC and suggest that you do with its stocks.
J7Z reached its all-time high on Jul 20, 2022 with the price of 153.574 CHF, and its all-time low was 101.213 CHF and was reached on Jan 18, 2024. View more price dynamics on J7Z chart.
See other stocks reaching their highest and lowest prices.
J7Z stock is 3.59% volatile and has beta coefficient of 0.42. Track JAZZ PHARMA PLC stock price on the chart and check out the list of the most volatile stocks — is JAZZ PHARMA PLC there?
Today JAZZ PHARMA PLC has the market capitalization of ‪5.99 B‬, it has decreased by 2.34% over the last week.
Yes, you can track JAZZ PHARMA PLC financials in yearly and quarterly reports right on TradingView.
JAZZ PHARMA PLC is going to release the next earnings report on Aug 6, 2024. Keep track of upcoming events with our Earnings Calendar.
J7Z earnings for the last quarter are 2.42 CHF per share, whereas the estimation was 3.77 CHF resulting in a −35.87% surprise. The estimated earnings for the next quarter are 4.28 CHF per share. See more details about JAZZ PHARMA PLC earnings.
JAZZ PHARMA PLC revenue for the last quarter amounts to ‪813.70 M‬ CHF despite the estimated figure of ‪860.59 M‬ CHF. In the next quarter revenue is expected to reach ‪906.77 M‬ CHF.
J7Z net income for the last quarter is ‪−13.19 M‬ CHF, while the quarter before that showed ‪79.27 M‬ CHF of net income which accounts for −116.64% change. Track more JAZZ PHARMA PLC financial stats to get the full picture.
No, J7Z doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 3, 2024, the company has ‪2.80 K‬ employees. See our rating of the largest employees — is JAZZ PHARMA PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JAZZ PHARMA PLC EBITDA is ‪1.13 B‬ CHF, and current EBITDA margin is 33.85%. See more stats in JAZZ PHARMA PLC financial statements.
Like other stocks, J7Z shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JAZZ PHARMA PLC stock right from TradingView charts — choose your broker and connect to your account.